A practical update on atrial fibrillation and novel oral anticoagulants

Log in or register to watch video.

Cardiologist Dr Bradley Wilsmore discusses the effective identification, diagnosis and management of atrial fibrillation in line with latest Australian guidelines, and explores the use of NOACs (novel oral anticoagulants) to reduce stroke risk in a safe and effective manner.

Questions asked in the video

  1. What is atrial fibrillation? 0:00
  2. How is atrial fibrillation identified using an ECG? 0:38
  3. How do the new Australian AF guidelines affect the CHA2DS2-VASc score? 1:41
  4. What are some common misconceptions regarding anticoagulant treatment? 3:13
  5. What are the differences between the available NOACs? 4:23
  6. What should you consider when switching from warfarin to a NOAC? 5:18
  7. What should you consider when prescribing NOACs to older patients? 6:10
  8. What should you consider when prescribing NOACs to patients with renal impairment? 7:37
  9. What is the risk of falls in patients on anticoagulation? 9:09
  10. What is the most important thing to remember when managing AF? 10:46

This activity is sponsored by Boehringer Ingelheim.